Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Biol Reprod ; 85(4): 823-33, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21653891

ABSTRACT

Despite numerous observations of the effects of estrogens on spermatogenesis, identification of estrogen-regulated genes in the testis is limited. Using rats in which irradiation had completely blocked spermatogonial differentiation, we previously showed that testosterone suppression with gonadotropin-releasing hormone-antagonist acyline and the antiandrogen flutamide stimulated spermatogenic recovery and that addition of estradiol (E2) to this regimen accelerated this recovery. We report here the global changes in testicular cell gene expression induced by the E2 treatment. By minimizing the changes in other hormones and using concurrent data on regulation of the genes by these hormones, we were able to dissect the effects of estrogen on gene expression, independent of gonadotropin or testosterone changes. Expression of 20 genes, largely in somatic cells, was up- or downregulated between 2- and 5-fold by E2. The unexpected and striking enrichment of transcripts not corresponding to known genes among the E2-downregulated probes suggested that these might represent noncoding mRNAs; indeed, we have identified several as miRNAs and their potential target genes in this system. We propose that genes for which expression levels are altered in one direction by irradiation and in the opposite direction by both testosterone suppression and E2 treatment are candidates for controlling the block in differentiation. Several genes, including insulin-like 3 (Insl3), satisfied those criteria. If they are indeed involved in the inhibition of spermatogonial differentiation, they may be candidate targets for treatments to enhance recovery of spermatogenesis following gonadotoxic exposures, such as those resulting from cancer therapy.


Subject(s)
Estradiol/therapeutic use , Estrogens/therapeutic use , Gene Expression Regulation/drug effects , Spermatogenesis/drug effects , Spermatogenesis/radiation effects , Testis/drug effects , Testis/metabolism , Androgen Antagonists/therapeutic use , Animals , Crosses, Genetic , Drug Therapy, Combination , Flutamide/therapeutic use , Gamma Rays , Gene Expression Regulation/radiation effects , Gonadotropin-Releasing Hormone/antagonists & inhibitors , Hormone Antagonists/therapeutic use , Insulin/genetics , Insulin/metabolism , Male , MicroRNAs/metabolism , Oligonucleotide Array Sequence Analysis , Oligopeptides/therapeutic use , Proteins/genetics , Proteins/metabolism , Rats , Rats, Inbred BN , Rats, Inbred Lew , Testis/pathology , Testis/radiation effects , Testosterone/antagonists & inhibitors
2.
Biol Reprod ; 82(1): 54-65, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19684331

ABSTRACT

Although gonadotropins and androgen are required for normal spermatogenesis and both testosterone and follicle-stimulating hormone (FSH) are responsible for the inhibition of spermatogonial differentiation that occurs in irradiated rats, it has been difficult to identify the specific genes involved. To study specific hormonally regulated changes in somatic cell gene expression in the testis that may be involved in these processes, without the complication of changing populations of germ cells, we used irradiated LBNF(1) rats, the testes of which contain almost exclusively somatic cells except for a few type A spermatogonia. Three different groups of these rats were treated with various combinations of gonadotropin-releasing hormone antagonist, an androgen receptor antagonist (flutamide), testosterone, and FSH, and we compared the gene expression levels 2 wk later to those of irradiated-only rats by microarray analysis. By dividing the gene expression patterns into three major patterns and 11 subpatterns, we successfully distinguished, in a single study, the genes that were specifically regulated by testosterone, by luteinizing hormone (LH), and by FSH from the large number of genes that were not hormonally regulated in the testis. We found that hormones produced more dramatic upregulation than downregulation of gene expression: Testosterone had the strongest upregulatory effect, LH had a modest but appreciable upregulatory effect, and FSH had a minor upregulatory effect. We also separately identified the somatic cell genes that were chronically upregulated by irradiation. Thus, the present study identified gene expression changes that may be responsible for hormonal action on somatic cells to support normal spermatogenesis and the hormone-mediated block in spermatogonial development after irradiation.


Subject(s)
Follicle Stimulating Hormone/metabolism , Gene Expression Regulation , Luteinizing Hormone/metabolism , Testis/metabolism , Testosterone/pharmacology , Animals , Flutamide/pharmacology , Gamma Rays , Gene Expression Profiling , Gene Expression Regulation/drug effects , Gene Expression Regulation/radiation effects , Germ Cells/drug effects , Germ Cells/metabolism , Germ Cells/radiation effects , Gonadotropin-Releasing Hormone/antagonists & inhibitors , Male , Oligonucleotide Array Sequence Analysis , Oligopeptides/pharmacology , Rats , Reverse Transcriptase Polymerase Chain Reaction , Testis/drug effects , Testis/radiation effects , Testosterone/blood
3.
Biol Reprod ; 77(2): 237-46, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17475932

ABSTRACT

Male mice that are homozygous for the juvenile spermatogonial depletion (jsd) mutation in the Utp14b gene undergo several waves of spermatogenesis. However, spermatogonial differentiation ceases and in adults, spermatogonia are the only germ cells that remain. To understand further the blockage in spermatogonial differentiation in Utp14b(jsd) mutant mice, we correlated the rate and severity of spermatogonial depletion and the restoration of spermatogenesis following the suppression of testosterone or elevation of testicular temperature with the genetic background. Testes from Utp14b(jsd) mutant mice on B6, C3H, and mixed C3H-B6-129 (HB129) genetic backgrounds all showed steady decreases in the numbers of normal spermatogonia between 8 wk and 20 wk of age. The percentages of tubules with differentiating germ cells were higher and the spermatogonia were more advanced in C3H- background than in B6- or HB129-background Utp14b(jsd) mice. Genetic crosses showed that the source of the Y chromosome was a major factor in determining the severity of spermatogonial depletion in Utp14b(jsd) mutant mice. When Utp14b(jsd) mutants were subjected to total androgen ablation or unilateral cryptorchidization, spermatogenic development recovered markedly in the C3H and HB129 background but showed less recovery in the B6-background mice. The differences noted between the strains in terms of the severity of spermatogonial depletion were not dependent upon testosterone level or scrotal temperature but correlated with the magnitudes of the effects of elevated temperature on normal and Utp14b(jsd) mutant spermatogenic cells. Thus, the abilities of germ cells in certain strains to survive elevated temperatures may be related to their abilities to maintain some degree of differentiation potential after the Utp14b(jsd) gene is mutated.


Subject(s)
Cell Differentiation/genetics , Mutation/genetics , Ribonucleoproteins, Small Nucleolar/genetics , Spermatogonia/cytology , Aging , Animals , Body Temperature , Cell Count , Chromosome Mapping , Crosses, Genetic , Gonadotropin-Releasing Hormone/antagonists & inhibitors , Heterozygote , Homozygote , Male , Mice , Mice, Inbred C3H , Scrotum , Species Specificity , Spermatogenesis/drug effects , Spermatogenesis/genetics , Testis/chemistry , Testosterone/analysis , Testosterone/blood , Y Chromosome/genetics
4.
Endocrinology ; 147(1): 472-82, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16210366

ABSTRACT

Simultaneous suppression of both testosterone and FSH with GnRH antagonists (GnRH-ant) reverses the radiation-induced block in spermatogonial differentiation in F1 hybrids of Lewis and Brown-Norway rats. Although addition of exogenous testosterone restores the block, it also raises FSH, and hence it had not been possible to conclusively determine which hormone was inhibiting spermatogonial differentiation. In the present study, we establish the relative roles of testosterone and FSH in this inhibition using three different approaches. The first approach involved the treatment of irradiated rats, in which differentiation was stimulated by GnRH-ant plus flutamide, with FSH for 2 wk; the FSH reduced the percentage of tubules that were differentiated (TDI) by about 2-fold, indicating that FSH does have an inhibitory role. The second approach involved treatment of irradiated, hypophysectomized rats with exogenous testosterone for 10 wk; testosterone also reduced the TDI, demonstrating that testosterone had a definite inhibitory effect, independent of pituitary hormones. Furthermore, in this protocol we showed that TDI in the hypophysectomized testosterone-treated group, which had higher intratesticular testosterone levels but lacked FSH, was slightly higher than the TDI in a GnRH-antagonist-testosterone-treated group of irradiated rats, which had normal physiological levels of FSH; this result supports a role for endogenous FSH in suppressing spermatogonial differentiation in the latter group. The third approach involved injection of an active anti-FSH antibody for 10 d in untreated, GnRH-ant plus flutamide-treated, or GnRH-ant plus testosterone-treated irradiated rats. This was not sufficient to increase the TDI. However, flutamide given in a similar treatment schedule did increase the TDI in GnRH-ant plus testosterone-treated rats. We conclude that both testosterone and FSH individually inhibit spermatogonial differentiation after irradiation, but testosterone is a more highly potent inhibitor than is FSH.


Subject(s)
Cell Differentiation/drug effects , Follicle Stimulating Hormone/pharmacology , Spermatogonia/cytology , Spermatogonia/radiation effects , Testosterone/pharmacology , Animals , Flutamide/pharmacology , Humans , Hypophysectomy , Male , Rats , Recombinant Proteins/pharmacology , Spermatogonia/drug effects
5.
Endocrinology ; 145(10): 4461-9, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15205377

ABSTRACT

Suppression of intratesticular testosterone (ITT) levels is required for spermatogenic recovery in rats after irradiation, but maintenance of peripheral testosterone (T) levels is important for many male functions. Considering the preservation of peripheral T while suppressing ITT, we tested the effects of a combination of a progestin, medroxyprogesterone acetate (MPA), plus T on spermatogenic recovery after irradiation, and compared its effects to those of T alone or T combined with estradiol (E2). Rats were given testicular irradiation (6 Gy) and treated during wk 3-7 after irradiation with MPA + T, or the individual steroids with or without GnRH antagonist (GnRH-ant), or GnRH-ant alone, or T + E2. Whereas GnRH-ant alone stimulated differentiation in 55% of tubules 13 wk after irradiation compared with 0% in irradiated-only rats, the addition of MPA reduced the percentage of tubules showing differentiation to 18%. However, T or MPA alone or the combination of the two induced germ cell differentiation in only 2-4% of tubules. In contrast, E2 stimulated differentiation in 88% of tubules, and T combined with E2 still resulted in differentiation in 30% of tubules. Although both MPA and E2 suppressed ITT levels to approximately 2% of control (2 ng/g testis), MPA was a less effective stimulator of spermatogenic recovery than E2 or GnRH-ant alone. MPA's function as a weak androgen was likely responsible for inhibiting spermatogenic recovery, as was the case for all other tested androgens. Thus, for clinical protection or restoration of spermatogenesis after radiation or chemotherapy by suppressing T production, MPA, at least in the doses used in the present study, is suboptimal. The combination of an estrogen with T appears to be most effective for stimulating such recovery.


Subject(s)
Estradiol/pharmacology , Medroxyprogesterone Acetate/pharmacology , Spermatogenesis/drug effects , Testis/radiation effects , Animals , Cell Differentiation , Drug Combinations , Gonadotropin-Releasing Hormone/antagonists & inhibitors , Hormones/blood , Male , Rats , Rats, Inbred Strains , Spermatogonia/cytology , Testosterone/pharmacology
6.
Biol Reprod ; 68(4): 1361-8, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12606425

ABSTRACT

Endothelin-converting enzyme 1 (ECE-1) is a key enzyme in the biosynthesis of endothelin 1 (ET-1), a potent regulator of ovarian function. Different ECE-1 isoforms are localized in distinct intracellular compartments. Thus, the spatial and temporal pattern of ECE-1 expression determines the site of big ET-1 activation and the bioavailability of ET-1. This study was undertaken to investigate the hormonal regulation and cell-specific expression of ECE-1 isoforms in endothelial and steroidogenic cells of bovine follicles and corpora lutea (CL). Using enriched follicular and luteal cell subpopulations and in situ hybridization techniques, we showed that the ECE-1 gene is expressed by both endothelial and steroidogenic cells; however, the intracellular ECE-1a isoform was present only in ET-1-expressing endothelial cells. Steroidogenic cells in follicles or in CL, deficient in ET-1, expressed only the plasma membrane ECE-1b isoform. The intensity of antisense ECE-1 labeling in the granulosa cell layer increased with follicular size; insulin-like growth factor I and insulin upregulated ECE-1 expression when cultured with granulosa cells, suggesting that these growth factors may increase ECE-1 in growing follicles. In contrast, ET-1 and LH downregulated ECE-1 in steroidogenic cells. This effect could account for low ECE (and ET-1) levels, which characterize the early luteal phase. These findings suggest that ECE-1 is regulated during different stages of the cycle in a physiologically relevant manner. The hormonal regulation and intracellular localization of bovine ECE-1 isoforms revealed in this study may provide new insights into ET-1 biosynthesis and mode of action in different cellular microenvironments within the ovary.


Subject(s)
Aspartic Acid Endopeptidases/metabolism , Insulin-Like Growth Factor I/pharmacology , Insulin/pharmacology , Luteinizing Hormone/pharmacology , Ovary/metabolism , Steroids/biosynthesis , Animals , Cattle , Cells, Cultured , Down-Regulation , Endothelin-1/metabolism , Endothelin-1/pharmacology , Endothelin-Converting Enzymes , Endothelium/cytology , Endothelium/drug effects , Endothelium/metabolism , Female , Isoenzymes/metabolism , Metalloendopeptidases , Ovarian Follicle/cytology , Ovarian Follicle/metabolism , Ovary/cytology , Ovary/drug effects , Up-Regulation
SELECTION OF CITATIONS
SEARCH DETAIL
...